NO20023380L - Indolderivater som MCP-1-reseptoragonister - Google Patents

Indolderivater som MCP-1-reseptoragonister

Info

Publication number
NO20023380L
NO20023380L NO20023380A NO20023380A NO20023380L NO 20023380 L NO20023380 L NO 20023380L NO 20023380 A NO20023380 A NO 20023380A NO 20023380 A NO20023380 A NO 20023380A NO 20023380 L NO20023380 L NO 20023380L
Authority
NO
Norway
Prior art keywords
mcp
receptor agonists
indole derivatives
indole
derivatives
Prior art date
Application number
NO20023380A
Other languages
English (en)
Norwegian (no)
Other versions
NO20023380D0 (no
Inventor
Alan Faull
Jason Grant Kettle
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of NO20023380D0 publication Critical patent/NO20023380D0/no
Publication of NO20023380L publication Critical patent/NO20023380L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
NO20023380A 2000-01-13 2002-07-12 Indolderivater som MCP-1-reseptoragonister NO20023380L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0000626.2A GB0000626D0 (en) 2000-01-13 2000-01-13 Chemical compounds
PCT/GB2001/000069 WO2001051466A1 (en) 2000-01-13 2001-01-11 Indole derivatives as mcp-1 receptor antagonists

Publications (2)

Publication Number Publication Date
NO20023380D0 NO20023380D0 (no) 2002-07-12
NO20023380L true NO20023380L (no) 2002-09-03

Family

ID=9883551

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20023380A NO20023380L (no) 2000-01-13 2002-07-12 Indolderivater som MCP-1-reseptoragonister

Country Status (25)

Country Link
US (1) US20030144339A1 (enExample)
EP (1) EP1252142A1 (enExample)
JP (1) JP2003519683A (enExample)
KR (1) KR20020064375A (enExample)
CN (1) CN1395565A (enExample)
AR (1) AR026839A1 (enExample)
AU (1) AU780992B2 (enExample)
BG (1) BG106894A (enExample)
BR (1) BR0107404A (enExample)
CA (1) CA2393592A1 (enExample)
CO (1) CO5271703A1 (enExample)
EE (1) EE200200394A (enExample)
GB (1) GB0000626D0 (enExample)
HK (1) HK1049486A1 (enExample)
HU (1) HUP0300694A3 (enExample)
IL (1) IL150272A0 (enExample)
IS (1) IS6429A (enExample)
MX (1) MXPA02006611A (enExample)
NO (1) NO20023380L (enExample)
NZ (1) NZ519312A (enExample)
PL (1) PL356031A1 (enExample)
RU (1) RU2002121636A (enExample)
SK (1) SK10072002A3 (enExample)
WO (1) WO2001051466A1 (enExample)
ZA (1) ZA200204354B (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9716657D0 (en) 1997-08-07 1997-10-15 Zeneca Ltd Chemical compounds
GB9902461D0 (en) 1999-02-05 1999-03-24 Zeneca Ltd Chemical compounds
AU2003215549A1 (en) * 2003-02-03 2004-08-30 Janssen Pharmaceutica N.V. Mercaptoimidazoles as ccr2 receptor antagonists
US8058320B2 (en) * 2004-09-13 2011-11-15 Kureha Corporation Thermally foamable microsphere, production method thereof, use thereof, composition containing the same, and article
WO2007065820A1 (en) 2005-12-09 2007-06-14 F. Hoffmann-La Roche Ag Tricyclic amide derivatives useful for treating obesity
US20080076120A1 (en) * 2006-09-14 2008-03-27 Millennium Pharmaceuticals, Inc. Methods for the identification, evaluation and treatment of patients having CC-Chemokine receptor 2 (CCR-2) mediated disorders
US7507736B2 (en) 2007-02-07 2009-03-24 Hoffmann-La Roche Inc. Indol-2-yl-piperazin-1-yl-methanone derivatives
US7981888B2 (en) * 2007-04-16 2011-07-19 Abbott Laboratories 1-oxyalkyl-2-carboxyl-7-nonsubstituted indole derivatives
WO2023224981A1 (en) * 2022-05-17 2023-11-23 Inipharm, Inc. Hsd17b13 inhibitors and uses thereof

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4529724A (en) * 1983-10-11 1985-07-16 Mcneilab, Inc. 6H-indolo[2,1-c][1,4]benzodiazepines and 12-oxo derivatives useful as antihypertensives
DE3907388A1 (de) * 1989-03-08 1990-09-13 Kali Chemie Pharma Gmbh Verfahren zur herstellung von indolcarbonsaeurederivaten
US5272145A (en) * 1989-08-22 1993-12-21 Merck Frosst Canada, Inc. (Quinolin-2-ylmethoxy)indoles as inhibitors of the biosynthesis of leukotrienes
US5081145A (en) * 1990-02-01 1992-01-14 Merck Frosst Canada, Inc. Indole-2-alkanoic acids compositions of and anti allergic use thereof
US5190968A (en) * 1991-09-30 1993-03-02 Merck Frosst Canada, Inc. (Polycyclic-arylmethoxy) indoles as inhibitors of leukotriene biosynthesis
US5290798A (en) * 1991-09-30 1994-03-01 Merck Frosst Canada, Inc. (hetero-arylmethoxy)indoles as inhibitors of leukotriene biosynthesis
US5273980A (en) * 1991-09-30 1993-12-28 Merck Frosst Canada Inc. Bicyclic-azaarylmethoxy) indoles as inhibitors of leukotriene biosynthesis
US5308850A (en) * 1991-09-30 1994-05-03 Merck Frosst Canada, Inc. (Bicyclic-hetero-arylmethoxy)indoles as inhibitors of leukotriene biosynthesis
US5389650A (en) * 1991-09-30 1995-02-14 Merck Frosst Canada, Inc. (Azaarylmethoxy)indoles as inhibitors of leukotriene biosynthesis
US5288743A (en) * 1992-11-20 1994-02-22 Abbott Laboratories Indole carboxylate derivatives which inhibit leukotriene biosynthesis
US5852046A (en) * 1993-08-03 1998-12-22 Hoechst Aktiengesellschaft Benzo-fused heterocyclic compounds having a 5-membered ring processes for their preparation their use as medicaments their use as diagnostic agents and medicaments containing them
US5686481A (en) * 1993-12-21 1997-11-11 Smithkline Beecham Corporation Endothelin receptor antagonists
US5482960A (en) * 1994-11-14 1996-01-09 Warner-Lambert Company Nonpeptide endothelin antagonists
US5684032A (en) * 1994-12-13 1997-11-04 Smithkline Beecham Corporation Compounds
WO1997035572A1 (en) * 1996-03-28 1997-10-02 Smithkline Beecham Corporation Carboxylic acid indole inhibitors of chemokines
EP0927167A1 (en) * 1996-08-14 1999-07-07 Warner-Lambert Company 2-phenyl benzimidazole derivatives as mcp-1 antagonists
GB9716657D0 (en) * 1997-08-07 1997-10-15 Zeneca Ltd Chemical compounds
GB9716656D0 (en) * 1997-08-07 1997-10-15 Zeneca Ltd Chemical compounds
GB9803228D0 (en) * 1998-02-17 1998-04-08 Zeneca Ltd Chemical compounds
GB9803226D0 (en) * 1998-02-17 1998-04-08 Zeneca Ltd Chemical compounds
GB9902461D0 (en) * 1999-02-05 1999-03-24 Zeneca Ltd Chemical compounds

Also Published As

Publication number Publication date
MXPA02006611A (es) 2002-09-30
KR20020064375A (ko) 2002-08-07
AU2532401A (en) 2001-07-24
WO2001051466A1 (en) 2001-07-19
HUP0300694A2 (hu) 2003-07-28
US20030144339A1 (en) 2003-07-31
NZ519312A (en) 2004-04-30
CA2393592A1 (en) 2001-07-19
PL356031A1 (en) 2004-06-14
JP2003519683A (ja) 2003-06-24
CN1395565A (zh) 2003-02-05
EP1252142A1 (en) 2002-10-30
HK1049486A1 (zh) 2003-05-16
CO5271703A1 (es) 2003-04-30
BG106894A (bg) 2003-04-30
BR0107404A (pt) 2002-10-08
ZA200204354B (en) 2003-09-01
NO20023380D0 (no) 2002-07-12
GB0000626D0 (en) 2000-03-01
HUP0300694A3 (en) 2005-08-29
SK10072002A3 (sk) 2003-06-03
AR026839A1 (es) 2003-02-26
AU780992B2 (en) 2005-04-28
IL150272A0 (en) 2002-12-01
IS6429A (is) 2002-06-19
EE200200394A (et) 2003-12-15
RU2002121636A (ru) 2004-01-10

Similar Documents

Publication Publication Date Title
NO20013809D0 (no) Indolderivater og anvendelse derav som MCP-1 antagonister
DK1309559T3 (da) 4-phenyl-pyridinderivater som neurokinin-1-receptorantagonister
DK1446379T3 (da) Arylanilin-beta2-adrenergiske receptoragonister
DK1049689T3 (da) 4-(2-keto-1-benzimidazolinyl)piperidinderivater som ORL1-receptoragonister
DK1102762T3 (da) 2-substituerede-1-piperidylbenzimidazolforbindelser som ORL1-receptoragonister
ATE392206T1 (de) Indolderivate als beta-2 agonisten
NO20031952L (no) 3-aroylinderivater og deres anvendelse som CB2 reseptoragonister
DE60007127D1 (de) N-pyrazol a2a rezeptor agonisten
DK1192169T3 (da) C-pyrazol A2A receptor-agonister
NO20032678D0 (no) NMDA reseptor agonist farmasöytiske sammensetninger
DK1305319T3 (da) 4-phenyl-pyridinderivater som neurokinin-1-receptorantagonister
NO20041237L (no) Indol-derivater som COX II-inhibitorer
DK1355639T3 (da) Substituerede carbostyrilderivater som 5-HT1A-receptorsubtypeagonister
NO20034130D0 (no) Benzimidazolderivater som modulerer kjemokinreseptor
NO20020565D0 (no) Interleukin-5-hemmende 6-azauracilderivater
NO20023380D0 (no) Indolderivater som MCP-1-reseptoragonister
NO20015737D0 (no) Indol derivater
DK1347974T3 (da) Aminotriazolopyridinderivater som adenosinreceptorligander
NO20020306L (no) Indolderivater
IS2431B (is) Nýjar indólafleiður
DK1305307T3 (da) Indolderivater
DK1347760T3 (da) Farmaceutiske kompositioner med NMDA receptor agonister
DK1207159T3 (da) Heteroaromatiske derivater som dopamin-D4-receptorantagonister

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application